Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
315,976,000
-
Total 13F shares
-
92,046,870
-
Share change
-
-1,311,640
-
Total reported value
-
$420,590,386
-
Put/Call ratio
-
64%
-
Price per share
-
$4.57
-
Number of holders
-
126
-
Value change
-
-$4,897,752
-
Number of buys
-
54
-
Number of sells
-
64
Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q4 2020
As of 31 Dec 2020 Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) had 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 92,046,870 shares of stock of the company.
Largest 10 holders included Fosun International Ltd, TPG Group Holdings (SBS) Advisors, Inc., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, Neuberger Berman Group LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, NORTHERN TRUST CORP, and PRUDENTIAL FINANCIAL INC.
This table shows 126 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.